An interventional study of zamzam water and tap water in Oligohydramnios, sponsored by Aswan University Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2021-08-09.
Sponsored by Aswan University Hospital · Not applicable, Interventional, and Treatment
The aim of this study is to evaluate the efficacy of drinking zamzam water versus tap water in increasing the AF index in women with oligohydramnios.
Oligohydramnios refers to decrease in amniotic fluid and it is defined as a deepest fluid pocket of less than 2 cm or an amniotic fluid index of 5 cm or less. Oligohydramnios complicates 0.5% to 8% of pregnancies, and 12 % if postdates When it occurs in first half of pregnancy it is associated with birth defects while in second half it causes poor fetal growth, malpresentations , FHR decelerations , MAS , Fetal suicidal syndrome and increases cesarean section and management and prognosis depend on gestational age
25 studies on the registry are indexed under Oligohydramnios; 5 are open to participants now.
This study's planned enrollment of 120 is above the median of 91 across 16 interventional studies indexed under Oligohydramnios.
Browse Oligohydramnios studies →Aswan University Hospital is the lead sponsor of 97 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patient will receive the normal need of daily requirement of water (2.5 liter) in form of zamzam water till patients deliver or till term
Dietary Supplement: zamzam water
will receive the normal need of daily requirement of water (2.5 liter) in form of tap water
Dietary Supplement: tap water
will receive the normal need of daily requirement of water (2.5 liter) in form of zamzam water till patients deliver or till term
Also known as: study group
will receive the normal need of daily requirement of water (2.5 liter) in form of tap water
Also known as: Active Comparator
amniotic fluid index
the change of the amniotic fluid volume
Time frame: 10 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2021 (actual). Primary completion is estimated for Sep 2021, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aswan University Hospital